Novartis Plans to Cut 1,400 Drug Sales Positions in U.S. as Patents Expire

Novartis Plans to Cut 1,400 Drug Sales Positions in U.S. as Patents Expire
Novartis AG plans to cut 1,400 sales jobs in the U.S. as the drugmaker prepares for patent expirations and product introductions.

Read more on Bloomberg

---

Orignal From: Novartis Plans to Cut 1,400 Drug Sales Positions in U.S. as Patents Expire